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Several studies (1–4) have reported that the relative risk of
cancer in smokers, compared with nonsmokers, is greater in
women than in men. These results have led to speculations about
the biologic mechanisms underlying this difference, such as a
molecular interaction between sex hormones and tobacco car-
cinogens. The news media have echoed widely such results,
perhaps because anything suggesting that women and men are
inherently different strikes a chord among the public.
In this commentary, I suggest that the evidence from these
studies is interpreted incorrectly, because of misunderstandings
about the meanings of relative risk versus absolute risk and the
meanings of statistical interaction versus biologic interaction.
RELATIVE RISK VERSUS ABSOLUTE RISK
To present my argument, I will use data from the study by
Castelao et al. (4) that compared smoking habits of case patients
diagnosed with bladder cancer with smoking habits of sex-
matched community control subjects. In this well-conducted
study, both case patients and control subjects were identified
from the same underlying population, validated instruments
were used to assess exposure, and sound statistical methods were
used to analyze results. Odds ratios (ORs) of cancer associated
with smoking were higher in women than in men, whether for
ever smoking (OR 2.8 [95% confidence interval 2.0 to 4.0]
for women and OR  2.4 [95% confidence interval  2.0 to
2.9] for men) or current smoking (OR  4.6 [95% confidence
interval  3.0 to 7.0] for women and OR  3.6 [95% confi-
dence interval  2.8 to 4.6] for men). In a regression model
predicting the risk of bladder cancer, the interaction between sex
and lifetime number of cigarettes smoked was statistically sig-
nificant.
From these results, Castelao et al. (4) concluded, “when com-
parable numbers of cigarettes are smoked, the risk of bladder
cancer may be higher in women than in men.” This message was
reproduced in the Journal’s Memo to the Media and was high-
lighted by the Associated Press (“Women smokers may face a
higher risk of bladder cancer than men who smoke the same
amount”) (5). These summary statements are wrong, because of
the unfortunate substitution of “risk” for “relative risk, as com-
pared with nonsmokers of the same sex.” When case patients
and control subjects are matched on sex, as they were in this and
previous studies (1–4), relative risks of cancer for women versus
men cannot be estimated. The statistically significant interaction
term only means that the relative risk of cancer associated with
smoking differs between men and women.
To demonstrate why this distinction is important, let us re-
construct the disease incidence patterns in the underlying popu-
lation (Table 1). This data reconstruction can be done for the
study by Castelao et al. (4) because both case patients and con-
trol subjects were representative of the underlying general popu-
lation. To define the populations at risk, we start by assuming
that there were equal numbers of men and women in the popu-
lation (say, 0.5 million men and 0.5 million women followed for
10 years; however, any large number would lead to the same
conclusion), and then we apply the prevalence rates of “ever
smoking” reported among control subjects by Castelao et al. (4),
i.e., 66.8% (788 male control subjects who ever smoked/1180
total male control subjects) among men and 55.1% (184 female
control subjects who ever smoked/334 total female control sub-
jects) among women (Table 1, A). Dividing the numbers of
cancer patients in each sex-smoking category (Table 1, B) by the
corresponding numbers of person-years produces estimates of
incidence rates of bladder cancer (Table 1, C). Reassuringly,
these rough estimates are comparable to population-based inci-
dence rates reported elsewhere (6). These estimates contradict
the authors’ conclusions that women are at greater risk of blad-
der cancer than men—in fact, the incidence of bladder cancer is
more than three times higher in men than in women, whether in
ever smokers or in never smokers (Table 1, D).
The substitution of “risk” for “relative risk” may have been
an oversight as a result of overzealous manuscript editing.1
However, numerous previous reports, all published in authori-
tative journals, have committed the same mistake. For example,
Risch et al. (1), having observed that relative odds of lung cancer
associated with smoking were higher in women than in men,
concluded: “In summary, our data suggest that female smokers,
dose-for-dose, are at higher risk of lung cancer than male smok-
ers.” Zang and Wynder, also commenting on studies of lung
cancer, stated, “given the same level of cigarette smoking ex-
posure, the risk of . . . lung cancer . . . is consistently higher for
women than for men” (2) and “dose for dose, females are more
susceptible to the effects of tobacco carcinogens than males” (3).
Coming as they do from sex-matched case–control studies, all of
these conclusions are similarly incorrect.
Relative risks tell only part of the story. Relative risks are
obtained by dividing each absolute risk (or incidence rate) by
that of the reference category: for a global analysis, women who
never smoked (Table 1, D) and, for a sex-stratified analysis,
never smokers of either sex (Table 1, E). Only the latter can be
estimated from a sex-matched case–control study. However, in
the reconstructed population experience, we can also compute
the absolute risks of bladder cancer that are attributable to male
sex, ever smoking, or both (Table 1, F). A new notion emerges:
The increase in the risk of bladder cancer associated with male
sex is more than twice as large among smokers as that among
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nonsmokers, or, adopting the perspective of sex-matched stud-
ies, the risk attributable to smoking is almost three times larger
in men than in women (Table 1, G). These results are impres-
sive, particularly if one is a male smoker.
Both the relative risk approach and the absolute risk approach
constitute legitimate viewpoints on a complex reality; neither is
right or wrong. Each serves a different purpose. For instance,
evidence exists that results presented in relative risk format are
more likely to induce behavior change in individuals (7). On the
other hand, absolute risk data may be more relevant for public
health decisions (8).
STATISTICAL INTERACTIONS
The relative risk and absolute risk analyses agree on one
thing: The effect of smoking on bladder cancer risk differs be-
tween men and women. This defines a statistical interaction
between smoking and sex. Paradoxically, however, the relative
risk approach finds that smoking is more harmful in women,
whereas the absolute risk analysis finds that it is more harmful
in men. How is this possible? The short answer is that both the
existence and the direction of an interaction depend on the un-
derlying statistical model; if different models are used, interac-
tions will differ too. A statistical interaction exists when cancer
risk data collected for two or more risk factors do not fit the
model (9). The relative risk model used by Castelao et al. (4) is
multiplicative: It requires that the relative risk associated with
the joint presence of two risk factors (here, smoking and male
sex) be the product of the two relative risks taken in isolation. If
I denotes cancer incidence and N, S, W, and M designate non-
smokers, smokers, women, and men, respectively, this multipli-
cative model can be written as:
IMS
IWN
=
IMN
IWN
×
IWS
IWN
. [1]
If the equality holds, the multiplicative model is correct, and
there is no interaction. If the equality does not hold, an interac-
tion exists. In our example (Table 1, D), multiplying the relative
risk of male sex among nonsmokers (relative risk 3.59) by the
relative risk of smoking in women (relative risk 2.81) predicts
a relative risk of 10.09 in men who smoke. Because the observed
value (relative risk 8.79) is lower, the required equality does
not hold, and a negative interaction is said to exist between male
sex and smoking on a multiplicative scale. This finding was
given much emphasis in the professional and lay media.
Now if the additive risk model is used, the reasoning is simi-
lar, but “product” is replaced by “sum,” and “relative risk” is
replaced by “attributable risk.” The additive model is written as:
IMS − IWN = IMN − IWN + IWS − IWN. [2]
In our example (Table 1, F), the absolute risk attributable to
smoking among women (6.06 cases of bladder cancer per 105
person-years) is added to the risk attributable to male sex among
nonsmokers (8.65 cases of bladder cancer per 105 person-years),
to yield an expected 14.71 additional cases per 105 person-years
in men who smoke, compared with women who do not. Because
the observed risk difference (26.03 cases per 105 person-years)
is much greater, there is a positive interaction between smoking
and the male sex on an additive scale.
The fact that statistical interactions can be contradictory, de-
pending on the risk scale used, is not unique to the problem
being examined in this commentary. It is arithmetically impos-
sible to make up a situation where there is neither a multiplica-
tive nor an additive interaction between two risk factors, except
for the trivial case where one of the presumed “risk factors” does
not influence the risk of disease. Whether the interaction is sta-
tistically significant or not is only a question of statistical power.
So far we have considered only two risk scales, the additive
and the multiplicative. The multiplicative scale is equivalent to
an additive scale after a logarithm transformation. The additive
model described in equation 2 simplifies to
IMS = IMN + IWS − IWN, [3]
and the multiplicative model described in equation 1 simplifies to
IMS =
IMN × IWS
IWN
[4]
Table 1. Reconstructed cohort study of bladder cancer in men and women,
ever smokers and never smokers, from the study by Castelao et al. (4)
Women Men
A) Person-years of follow-up*
Never smokers 2 245 000 1 660 000
Ever smokers 2 755 000 3 340 000
B) Total cases of bladder cancer [from (4)]
Never smokers 75 199
Ever smokers 259 981
C) Incidence rate of bladder cancer
(cases per person-years), or absolute risk†
Never smokers 3.34 per 105 11.99 per 105
Ever smokers 9.40 per 105 29.37 per 105
D) Relative risks of bladder cancer in all subgroups
compared with women who never smoked
Relative risk
of bladder
cancer in men
Never smokers 1.00 3.59 3.59
Ever smokers 2.81 8.79 3.12
E) Relative risks of bladder cancer in ever smokers,
stratified by sex
Never smokers 1.00 1.00
Ever smokers 2.81 2.45
F) Attributable risks of bladder cancer in all sub-
groups compared with women who never smoked
Risk of bladder
cancer attributable
to male sex
Never smokers 0 8.65 per 105 8.65 per 105
Ever smokers 6.06 per 105 26.03 per 105 19.97 per 105
G) Risk of bladder cancer attributable to ever smoking,
stratified by sex
Never smokers 0 0
Ever smokers 6.06 per 105 17.38 per 105
*Assume 500 000 men and 500 000 women, followed for 10 years, and apply
the prevalence of ever smoking as described previously (4).
†The “incidence rate” is given by the number of new cases of disease divided
by the number of person-years at risk, and the “absolute risk” is given by the
proportion of persons initially free of disease who develop the disease over a
given period. The two notions are equivalent as long as risk is low, as in this
example, where the cumulative 10-year risk of bladder cancer ranges from
0.035% in a female nonsmoker to 0.3% in a male smoker.
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which becomes, after logarithm transformation,
logIMS = logIMN + logIWS − logIWN. [5]
Logarithms aside, equations 3 and 5 are identical. It turns out
that the logarithm is a special case of a family of power trans-
formations (10), of the general form:
Tpx =
xp − 1
p , for p  0,
and
Tpx = logex for p = 0.
The simple additive scale also is a special case, where p  1.
Under certain conditions (each risk factor must increase the
incidence of disease, whether the other risk factor is present or
absent), a value for p can be found that will eliminate interaction
altogether. By trial and error, for the bladder cancer data (Table
1, C), interaction disappears for p  0.12. Indeed, T0.12(29.37)
 T0.12(11.99) + T0.12(9.40) – T0.12(3.34). Thus, the same risk
data are compatible with a positive interaction (on an additive
scale), a negative interaction (after logarithm transformation),
and no interaction (after transformation of power  0.12).
The message is loud and clear: If an “interaction” can be
reversed or eliminated by statistical manipulation, it must be of
a statistical nature, not of a biologic nature. To recount: A sta-
tistical interaction exists when the observed risk patterns of dis-
ease in populations do not fit predictions from a particular sta-
tistical model. In contrast, biologic interaction refers to causal
pathways of disease in individuals. The two notions, despite the
unfortunate shared name, operate on different conceptual planes.
CAUSAL DISEASE PATHWAYS
If biologic and statistical interactions address different as-
pects of reality, can the observed statistical risk patterns tell us
anything about the pathogenesis of bladder cancer? According to
epidemiologists Rothman and Greenland (11), the answer is a
qualified “yes.” Their model of disease causation states that
disease occurs when a “sufficient cause” is formed in an indi-
vidual. Smoking is not a sufficient cause of bladder cancer. If it
were, all smokers would have this disease. For bladder cancer to
occur in a smoker (male or female), additional conditions must
be met. These conditions may include, among others, genetic
predisposition, previous DNA damage, exposure to other envi-
ronmental carcinogens, and immune reaction. The conjunction
of conditions (including smoking) that triggers necessarily the
occurrence of bladder cancer is called a sufficient cause, and the
components of the sufficient cause are said to “interact” on a
biologic level.
Several sufficient causes may exist for the same disease, and
each usually requires several components. Let us imagine that
smoking and male sex (or rather specific carcinogens linked
with these labels) belong only to separate sufficient causes of
bladder cancer: Smoking requires one set of conditions to pro-
duce bladder cancer, and male sex requires a fully independent
set of conditions. In this case, smoking-related bladder cancer
and male-sex-related bladder cancer develop independently,
even in male smokers, and the risks of bladder cancer attribut-
able to each risk factor should be additive (11). Since the addi-
tive model is obviously wrong (Table 1, C), it is possible that
both smoking and male sex may contribute to at least one suf-
ficient cause of bladder cancer—in other words, that they inter-
act in a biologic sense. Note that it is not the negative multipli-
cative interaction, but the positive additive interaction, that leads
to this possibility. But there is at least one alternative explana-
tion: Smoking may be merely associated with one of the unmea-
sured components of the sufficient cause involving male sex (or
vice versa). For instance, if alcohol consumption was a compo-
nent cause of bladder cancer associated with male sex and if
smokers tended to drink more than nonsmokers, a positive ad-
ditive interaction would appear between smoking and male sex.
A WAY OUT?
Correcting the first issue addressed in this commentary (i.e.,
misinterpretation of relative risk estimates) requires epidemio-
logic training, cautious interpretation of results, and careful
proofreading of manuscripts before submission and after editing.
The misunderstanding of interaction, statistical or biologic, will
be more difficult to eradicate. The underlying concepts are fairly
abstract and require familiarity with mathematical expressions.
Greenland and Rothman (9) suggest removing “interaction”
from the statistical vocabulary and replacing this term by more
precise phrases, such as “heterogeneity of effect on a multipli-
cative scale.” Whether this proposal gains acceptance remains to
be seen, but a little jargon may be an acceptable price to pay for
better communication. Other proposals to distinguish statistical
and biologic interactions are most welcome.
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NOTES
1Editor’s note: The omission of the concept of relative risk was not the result
of overzealous editing, but rather, underzealous editing or a “sub-additive inter-
action” between author, senior editor, and editorial board.
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